122 related articles for article (PubMed ID: 34407971)
1. Recurrent Human Papillomavirus-Related Head and Neck Cancer Undergoes Metabolic Reprogramming and Is Driven by Oxidative Phosphorylation.
Vyas A; Harbison RA; Faden DL; Kubik M; Palmer D; Zhang Q; Osmanbeyoglu HU; Kiselyov K; Méndez E; Duvvuri U
Clin Cancer Res; 2021 Nov; 27(22):6250-6264. PubMed ID: 34407971
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus-associated head and neck squamous cell carcinoma cells rely on glycolysis and display reduced oxidative phosphorylation.
Li N; Chamkha I; Verma G; Swoboda S; Lindstedt M; Greiff L; Elmér E; Ehinger J
Front Oncol; 2023; 13():1304106. PubMed ID: 38273844
[TBL] [Abstract][Full Text] [Related]
4. NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer.
Schrank TP; Prince AC; Sathe T; Wang X; Liu X; Alzhanov DT; Burtness B; Baldwin AS; Yarbrough WG; Issaeva N
Oncotarget; 2022; 13():707-722. PubMed ID: 35634245
[TBL] [Abstract][Full Text] [Related]
5. Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Prusinkiewicz MA; Gameiro SF; Ghasemi F; Dodge MJ; Zeng PYF; Maekebay H; Barrett JW; Nichols AC; Mymryk JS
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968678
[TBL] [Abstract][Full Text] [Related]
6. mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer.
Coppock JD; Lee JH
World J Otorhinolaryngol Head Neck Surg; 2016 Jun; 2(2):76-83. PubMed ID: 29204551
[TBL] [Abstract][Full Text] [Related]
7. EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.
Oyelakin A; Nayak KB; Glathar AR; Gluck C; Wrynn T; Tugores A; Romano RA; Sinha S
NAR Cancer; 2022 Jun; 4(2):zcac017. PubMed ID: 35664541
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response.
Naumann FV; Kaanders JHAM; Peeters WJM; Adema GJ; Sweep FCGJ; Bussink J; Span PN
Clin Transl Radiat Oncol; 2024 Mar; 45():100726. PubMed ID: 38292333
[TBL] [Abstract][Full Text] [Related]
9. Combinational therapy targeting the MET-mTOR-ROS loop disrupts mitochondrial autoregulatory machinery of liver cancer.
Huang X; Zhang G; Bai X; Liang T
Clin Transl Med; 2020 Dec; 10(8):e237. PubMed ID: 33377662
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.
Lu J; Cannizzaro E; Meier-Abt F; Scheinost S; Bruch PM; Giles HA; Lütge A; Hüllein J; Wagner L; Giacopelli B; Nadeu F; Delgado J; Campo E; Mangolini M; Ringshausen I; Böttcher M; Mougiakakos D; Jacobs A; Bodenmiller B; Dietrich S; Oakes CC; Zenz T; Huber W
Nat Cancer; 2021 Aug; 2(8):853-864. PubMed ID: 34423310
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level.
Wu Y; Yang S; Ma J; Chen Z; Song G; Rao D; Cheng Y; Huang S; Liu Y; Jiang S; Liu J; Huang X; Wang X; Qiu S; Xu J; Xi R; Bai F; Zhou J; Fan J; Zhang X; Gao Q
Cancer Discov; 2022 Jan; 12(1):134-153. PubMed ID: 34417225
[TBL] [Abstract][Full Text] [Related]
12. GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner.
Park MS; Yang AY; Lee JE; Kim SK; Roe JS; Park MS; Oh MJ; An HJ; Kim MY
Cancer Lett; 2021 Aug; 521():294-307. PubMed ID: 34416337
[TBL] [Abstract][Full Text] [Related]
13. Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer.
Mostaghel EA; Marck BT; Kolokythas O; Chew F; Yu EY; Schweizer MT; Cheng HH; Kantoff PW; Balk SP; Taplin ME; Sharifi N; Matsumoto AM; Nelson PS; Montgomery RB
Clin Cancer Res; 2021 Nov; 27(21):6001-6011. PubMed ID: 34407973
[TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma.
Donati G; Ravà M; Filipuzzi M; Nicoli P; Cassina L; Verrecchia A; Doni M; Rodighiero S; Parodi F; Boletta A; Vellano CP; Marszalek JR; Draetta GF; Amati B
Mol Oncol; 2022 Mar; 16(5):1132-1152. PubMed ID: 34632715
[TBL] [Abstract][Full Text] [Related]
15. Functional HPV-specific PD-1
Eberhardt CS; Kissick HT; Patel MR; Cardenas MA; Prokhnevska N; Obeng RC; Nasti TH; Griffith CC; Im SJ; Wang X; Shin DM; Carrington M; Chen ZG; Sidney J; Sette A; Saba NF; Wieland A; Ahmed R
Nature; 2021 Sep; 597(7875):279-284. PubMed ID: 34471285
[TBL] [Abstract][Full Text] [Related]
16. TSPO is a potential independent prognostic factor associated with cellular respiration and p16 in head and neck squamous cell carcinoma.
Tuominen S; Nissi L; Kukkula A; Routila J; Huusko T; Leivo I; Minn H; Irjala H; Löyttyniemi E; Ventelä S; Sundvall M; Grönroos TJ
Front Oncol; 2023; 13():1298333. PubMed ID: 38162485
[TBL] [Abstract][Full Text] [Related]
17. Prognosis to Radiation Unlocked: How Hypoxia Methylome May Hold the Key in HNSCC.
Heft Neal ME; Brenner JC
Clin Cancer Res; 2023 Aug; 29(16):2954-2956. PubMed ID: 37310809
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection.
Qiu X; Li Y; Zhang Z
Cell Oncol (Dordr); 2023 Aug; 46(4):847-865. PubMed ID: 37040057
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of oral human papillomavirus infection in healthy population and head and neck cancer.
Vani NV; Madhanagopal R; Swaminathan R; Ganesan TS
Cancer Med; 2023 May; 12(10):11731-11745. PubMed ID: 36846921
[TBL] [Abstract][Full Text] [Related]
20. The role of cancer cell bioenergetics in dormancy and drug resistance.
Tau S; Miller TW
Cancer Metastasis Rev; 2023 Mar; 42(1):87-98. PubMed ID: 36696004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
